[An update on hepatitis E].
The hepatitis E virus (HEV) is an RNA virus transmitted via the fecal-oral route or through uncooked animal meat products. Of the 4 known genotypes, genotype 3 is responsible for autochthonous infections in industrialized countries, with a seroprevalence in Switzerland estimated as high as 22%. The majority of infections is asymptomatic but a minority of patients, notably men over 50 or with underlying liver disease, can present with severe acute hepatitis. Chronic hepatitis E with HEV of genotype 3 has been observed in immunosuppressed patients, mostly transplant recipients. Serology is not sufficiently sensitive, especially in immunosuppressed patients, making PCR identification the preferred test for diagnosing active infection. Ribavirin or interferon-alpha can be used to treat chronic hepatitis E if reduction of immunosuppressive treatment does not result in viral elimination.
Service de gastroentérologie et d'hépatologie, CHUV, 1011 Lausanne. philippe.hiroz@chuv.ch
P
P
Hiroz
J
J
Gouttenoire
V L
VL
Dao Thi
R
R
Sahli
A
A
Telenti
D
D
Moradpour
C
C
Doerig
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D016751:Hepatitis E / Q000453:epidemiology / Q000628:therapy* / Q000821:virology; D016752:Hepatitis E virus / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D012737:Sex Factors; D013557:Switzerland / Q000453:epidemiology; D055815:Young Adult
D000998:Antiviral Agents